Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount

AORT

Healthcare
Artivion, Inc. · Medical Devices
Trades
6
Politicians
0
Buys
0
Sells
2
Trades
6
Politicians
0
Buys
0
Sells
2
AORTvs S&P 500 (normalized)
|to
No price data available
AORT S&P 500 Buy Sell
Range
PoliticianActionDescriptionAmountTradedFiled
Gilbert CisnerosD
SellArtivion, Inc. Common Stock$1K - $15KOct 9, 2025Nov 18, 2025
Tina SmithD
BuyArtivion, Inc. Common Stock$50K - $100KNov 16, 2023Nov 20, 2023
Tina SmithD
BuyArtivion, Inc. Common Stock$50K - $100KNov 10, 2023Nov 20, 2023
Josh GottheimerD
BuyArtivion, Inc.$1K - $15KJul 14, 2023Aug 8, 2023
Josh GottheimerD
SellArtivion, Inc.$1K - $15KJun 13, 2023Jul 6, 2023
Tina SmithD
BuyArtivion, Inc. Common Stock$50K - $100KSep 23, 2022Oct 17, 2022

Artivion, Inc. (AORT) Congressional Stock Trades

This page tracks congressional stock trading activity in Artivion, Inc. (AORT) in the Healthcare sector. Disclosed Capitol has indexed 6 disclosed congressional trades involving AORT. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.

As of November 2025 — Disclosed Capitol has tracked 6 disclosed congressional trades in Artivion, Inc. (AORT) — 2 sells with no recorded buys — led by Tina Smith (D).

Which members of Congress trade Artivion, Inc.?

  • Tina Smith (D) — 3 disclosed trades in AORT
  • Josh Gottheimer (D) — 2 disclosed trades in AORT
  • Gilbert Cisneros (D) — 1 disclosed trade in AORT

Recent AORT congressional trades

DatePoliticianPartyActionAmount
Oct 9, 2025Gilbert CisnerosDSale$1,001 - $15,000
Nov 16, 2023Tina SmithDBuy$50,001 - $100,000
Nov 10, 2023Tina SmithDBuy$50,001 - $100,000
Jul 14, 2023Josh GottheimerDBuy$1,001 - $15,000
Jun 13, 2023Josh GottheimerDSale$1,001 - $15,000
Sep 23, 2022Tina SmithDBuy$50,001 - $100,000

Buy vs. sell ratio & volume

Across the 6 disclosed congressional trades in Artivion, Inc. (AORT), members of Congress have reported 0 buys and 2 sells. The average 30-day alpha vs. the S&P 500 is 4.68%.

Does Artivion, Inc. receive U.S. government contracts?

As of June 2026, Artivion, Inc. has 37 federal contract award records on file from USAspending.gov — most recently $58K from the Department of Veterans Affairs on 2026-06-29.

Award dateAgencyAmount
2026-06-29Department of Veterans Affairs$58K
2026-05-26Department of Veterans Affairs$58K
2026-04-20Department of Veterans Affairs$50K
2026-01-13Department of Veterans Affairs$50K
2026-01-05Department of Veterans Affairs$50K
2025-12-16Department of Veterans Affairs$50K
2025-11-25Department of Veterans Affairs$64K
2025-07-09Department of Veterans Affairs$50K
2025-07-01Department of Veterans Affairs$50K
2024-12-18Department of Veterans Affairs$50K

Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.

Artivion, Inc. financial snapshot (FY2025)

For fiscal year 2025, Artivion, Inc. reported revenue of $441.3M and net income of $9.8M, per SEC filings.

Revenue
$441.3M
Gross profit
$284.2M
Operating income
$33.7M
Net income
$9.8M
Diluted EPS
$0.21
Gross margin
64.4%
Net margin
2.2%
Free cash flow
$839K

Most recent reported quarter: Q2 FY2026 — revenue $125.8M, net income -$13.5M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.